当前位置:首页 - 行情中心 - 博济医药(300404) - 财务分析 - 利润表

博济医药

(300404)

  

流通市值:18.82亿  总市值:28.37亿
流通股本:1.50亿   总股本:2.27亿

利润表

按照会计年度查询:
报告期2021-03-312020-12-312020-09-302020-06-30
一、营业总收入55,245,275.36260,468,434.47176,984,092.89110,045,597.78
营业收入55,245,275.36260,468,434.47176,984,092.89110,045,597.78
二、营业总成本50,308,938.58232,637,126151,419,276.6993,639,638.33
营业成本29,668,669.77146,655,841.5792,420,774.3458,359,235.19
营业税金及附加684,768.762,202,666.871,124,551.62529,515.38
销售费用3,265,991.6314,048,552.139,863,299.285,189,808.9
管理费用9,933,736.0442,026,131.8930,214,991.918,197,935.79
财务费用242,412.771,268,179.691,011,451.97625,804.98
资产减值损失-456,614.7-6,414,402.83----
三、其他经营收益182,158.54-2,277,362.28-849,894.12214,432.51
允许价值变动净收益--------
投资净收益-525,223.32,975,062.59419,901.23559,373.78
联营、合营企业投资收益-644,457.22,460,940.8119,809.65421,351.05
汇兑净收益--------
四、营业利润11,126,644.3227,407,685.5328,229,425.0316,955,726.42
营业外收入106.48380,465.32404,016.26273,806.32
营业外支出14,486.5116,826.9114,926.918,907.5
非流动资产处置净损失--------
五、利润总额11,112,264.2927,771,323.9428,618,514.3817,220,625.24
所得税1,212,971.392,903,011.414,181,302.492,354,505.57
未确认的投资损失--------
六、净利润(百万元)7.3716.9919.4711.87
少数股东损益2,530,136.887,879,670.724,969,938.892,991,166.25
归属于母公司股东的净利润7,369,156.0216,988,641.8119,467,27311,874,953.42
七、每股收益0.030.080.090.05
基本每股收益0.030.080.090.05
稀释每股收益0.030.070.090.05
TOP↑